ALSO NOTED: Vectura touts Parkinson's data; Pharmorphix is bought out; and much more...

> Vectura is touting the positive outcome of a Phase II study of VR040 for Parkinson's disease. Report

> Sigma-Aldrich has acquired the UK's Pharmorphix, which provides research services to biotech companies, for an undisclosed amount. Report

> Mexico has approved Merck's diabetes drug Januvia. It's a first approval for Merck, which is awaiting a decision by the FDA. Report

> Lipid Sciences raised $6.3 million through a private placement. Release

And Finally… Despite a $28 billion bioterror program in the U.S., experts say that the country is still highly vulnerable to an attack. Article